Innovative Bioresearch: Fighting Cancer and AIDS with Blockchain

in #innbc6 years ago (edited)

The spread of cancer and AIDS has been one of the most troubling global issues for humanity lately. The foremost reason is that these diseases are hard to beat. They show no mercy, no matter if you are a regular person or an iconic artist who can afford the best doctors and facilities in the world.

https://www.innovativebioresearch.com/

Although humanity has been fighting and researching about these diseases for a while now, the prevention and control system remains far from perfect. The founders of Innovative Bioresearch believe that creating a decentralized database on blockchain could solve several issues with the system.

Powering and funding AIDS research

The key problem that Innovative Bioresearch aims to solve is that today research teams have to go through the exhausting process of accessing clinical data before they can apply it. As a result, it takes a lot of time before new therapeutic strategies can be put into action (which is easily critical when it comes to handling diseases like AIDS and cancer) and the probability of a human error is high. Innovative Bioresearch believes they can overcome that by creating a decentralized database and an application for HIV seropositive users. The database and the app are meant to be a resource for their research, while ICO and tokens are thought to fund it. Although today Innovative Bioresearch focus their effort on AIDS, they provide a detailed vision of how cancer could be treated within the projects yet to be launched.

Cars for tokens

Innovative Bioresearch comes up with a rather unusual model of token utility. Typically, tokens are used to pay for the services and goods within a new platform. The founders of this project promise that you will be able to purchase JDM cars from their INNBC JDM Online Garage which will be launched after the public token sale, for INNBC tokens. This is because Jonathan Fiori, the founder of Innovative Bioresearch, is involved in importing Japanese domestic market cars. However, the company promises to introduce premium features with their app which is scheduled to be launched 3-6 months after the completion of the ICO.

Platform for research and communication

Novel AIDS cure research


The Innovative Bioresearch ICO will fund the research about handling HIV with SupT1 cell infusion. Mice trials have already demonstrated that the therapy is highly worth further research.

Decentralized base of clinical data


By introducing a decentralized database Innovative Bioresearch aims to make clinical data accessible to all researchers and doctors, as opposed to being monopolized and exclusively controlled by pharma or governments.

https://www.innovativebioresearch.com/

You’re Not Alone App


Innovative Bioresearch will develop the You’re Not Alone application that will allow:
  • clinicians to store their empirical data and make it easily accessible and applied by their colleagues;
  • HIV seropositive people to keep track of the research staying up-to-date on the latest scientific achievements in this field and participate in discussions sharing their experience and learning from others.

Competition

A similar project that has the most mentions on the Internet is HEAL Bonds. However, all of the publications date back to 2016. The news section on their official website also stopped being updated in 2016. The latest post in their Twitter account was published on the January 12th. Another such project, Dermavir, completed their ICO on May 30th with as yet undisclosed results. We couldn’t find projects other than that. However, the discussion around this specific application of blockchain has been around for a while now.

As for the proposed therapy itself, Innovative Bioresearch estimates that their treatment will be cheaper than the now widely used antiretroviral therapy (ART), as well as than any gene therapy using modified autologous cells offered by their competitors. This remains subject to investigation by medical experts.

INNBC token sale summary

Conclusion

Innovative Bioresearch creates the impression of a project that aims to solve a very genuine, even critical problem. It is run by a small team of three where the company’s owner, Jonathan Fior is a leader with a Bachelor’s degree in Medical Biotechnology. The research is conducted in collaboration with other companies that play the role of contract research organizations.

It requires specific knowledge and expertise in medical science to evaluate the research, its outcome, and proposed therapeutical solution. We could only find two projects that are building upon the same model that implies blockchain as an instrument to fund HIV research: one that looks half-abandoned and another one with yet unclear results. Innovative Bioresearch wants to allow you to exchange their tokens for cars, which is interesting, unusual and a bit controversial. Their public token sale has been live since May 1st and will be running through August 1st. Typically, ICO projects have more following at the point when they launch public sale which is not the case with Innovative Bioresearch that only has around 500 followers on each social platform. We believe that this is due to the lack of marketing and PR, because the company doesn’t even have a marketer or PR specialist. Therefore, we would strongly advise Innovative Bioresearch to put more effort into promotion, so that their overall warmly welcomed initiative doesn’t go unnoticed.

Links:

Website: https://www.innovativebioresearch.com
Whitepaper: https://bit.ly/2LzMS0X
Telegram: https://t.me/innovativebioresearch
Facebook: https://www.facebook.com/blockshipping/
Twitter: https://twitter.com/InnBioresearch
YouTube: https://bit.ly/2JkGQVc
ANN: https://bitcointalk.org/index.php?topic=3378302
Author: https://bitcointalk.org/index.php?action=profile;u=980049

ETH: 0xda2574CFeB7De808c08E542000E62C4949ee3233

Disclaimer:
This review by Bonanza Kreep is all opinion and analysis, not investment advice.

Coin Marketplace

STEEM 0.30
TRX 0.11
JST 0.033
BTC 64275.05
ETH 3147.49
USDT 1.00
SBD 4.29